Patent ID: 7569569
Filing Date: 2009-08-04
Classification: A61P,C07D

Abstract:
1. A pharmaceutical composition comprising an effective amount of a compound of the formula or the pharmaceutically acceptable salt thereof; wherein R wherein m is 0, 1, 2 or 3; n is 0, 1 ,2 or 3; X, B and D are each CR A and E are each CR R wherein p is 0, 1, 2 or 3; and Z is hydroxy, (C R with the proviso that when R with the proviso that when R alone or in combination with one or more additional agents which modulate a mammalian immune system or with antiinflammatory agents, wherein said one or more additional agents is selected from the group consisting of cyclosporine A, rapamycin, tacrolimus, leflunomide, deoxyspergualin, mycophenolate, azathioprine, daclizumab, muromonab-CD a pharmaceutically acceptable carrier.